Retinal Insider

Machine Learning for Diabetic Retinopathy

Adding computers to the mix may help ophthalmologists around the world catch and treat DR more effectively.

OCT Technology: Will We Be “Swept” Away?

A look at the differences between spectral-domain and swept-source OCT, and the potential clinical benefits of swept-source.

Combo Therapy: When One Drug’s Not Enough

A look at researchers’ attempts to gang up on wet age-related macular degeneration.

A Review of Portable Retinal Imaging

A guide to using common devices such as smartphones as well as more exotic consumer-level cameras to capture images.

The Clinical Utility of OCT Angiography

Retina specialists experienced in OCTA discuss the strengths—and the limitations—of this promising new technology.

Ocular Vitamins: Who Benefits?

It may be possible to stretch the boundaries of the AREDS’ findings and still give patients positive results.

Avoiding the Traps of Hydroxychloroquine Use

Proper communication between specialties and using the correct formula for dosing can curb toxicity.

A Deeper Look at Protocols S and T

An experienced clinician and retinal researcher discusses what the trials’ findings might mean for clinical practice.

In Search of the Best AMD Therapy

A look at the ways researchers and clinicians are trying to overcome the shortcomings of current therapies.

Targeting VEGF’s Silent Partners in DME

A look at what’s going on behind the scenes in patients for whom anti-VEGF therapy has little or no effect.